2025 annual financial data

RenovoRx 2025 Financial results

Direct answer

Revenue was 1,123,000 USD.

Operating income was -12,510,000 USD and net income was -11,168,000 USD.
Operating cash flow was -10,973,000 USD.

Get free RenovoRx email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,123,000 USD
Operating income
-12,510,000 USD
Net income
-11,168,000 USD
Operating cash flow
-10,973,000 USD